Alzheimer’s

First Opinion By Dennis J. Selkoe

Biogen’s good news on aducanumab could ‘open the floodgates’ for Alzheimer’s drugs

In the Lab By Sharon Begley

New prize offers $2 million for finding key to Alzheimer’s in past research

Pharma By Sharon Begley

That pathetic Alzheimer’s pipeline? It’s even worse than you think

Pharmalot By Ed Silverman

Pharmalittle: Biogen argues investors overreacted; AstraZeneca wins a key immunotherapy approval

Health By Damian Garde

Fans ‘didn’t care if he messed up’: Glen Campbell’s doctor discusses his struggle with Alzheimer’s

Biotech By Sharon Begley

In small Alzheimer’s study, hints of modest benefit from unusual drug

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Former compounder told staff to stop ‘fudging’ after meningitis outbreak

Pharmalot By Ed Silverman

Lilly cuts 200 R&D jobs, but insists an Alzheimer’s failure is not the cause

Signal Podcast By Luke Timmerman and Meg Tirrell

Listen: Episode 19: From poop transplants to pill politics, here’s the year in ‘Signal’

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Handful of doctors responsible for high levels of fentanyl prescriptions

Health By Judith Graham

Loneliness is bad for your health. This new campaign aims to curb isolation

In the Lab By Sharon Begley

Their brains had the telltale signs of Alzheimer’s. So why did they still have nimble minds?

Politics By Rebecca Robbins

Alzheimer’s is eroding his memory, but not his determination to vote

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill

In the Lab By Bryan Marquard — Boston Globe

MIT’s Susan Lindquist, a pioneer in science, dies at 67

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: New bill would create review board for drug prices

Business By Damian Garde

A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it

In the Lab By Usha Lee McFarling

Peter Walter just won the Breakthrough Prize. His work? Trying to heal human brains

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA fast tracks Biogen drug for Alzheimer’s

Health By Dylan Scott

Gene Wilder died of Alzheimer’s. His family explains why they didn’t disclose his diagnosis

Endnotes By Bob Tedeschi

How do you honor a dementia patient’s end-of-life-wishes?

First Opinion By Gary W. Small

Stop undertreating Alzheimer’s disease

In the Lab By Sharon Begley

Alzheimer’s researchers seethe over years of missteps after latest drug failure

Biotech By Damian Garde

Promising Alzheimer’s treatment flops in new trial, crushing hopes

Health By Megan Thielking

$75 for reminders to eat: Alzheimer’s patients face flurry of fees while waiting for specialized care